3rd Quarter - Report

MAYO CLINIC for MAYO CLINIC

Firm
Client
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Lab payments (PAMA); Research Funding; Regulatory Relief, Animal Welfare Act/Farm Bill, Laboratory Diagnostic Tests; International shipments of lab specimens.

LobbyistCovered position, as disclosed
JENNIFER MALLARD Director, Federal Government Relations

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Alcohol and Drug Abuse ALC

Opioid Epidemic

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

Tax Reform; Tax Cuts and Jobs Act (H.R. 1)

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (115th)

Health Issues HCR

Telemedicine; Laboratory Medicine payment and oversight

LobbyistCovered position, as disclosed
JENNIFER MALLARD Director, Federal Government Relations

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Trucking/Shipping TRU

International shipments of lab specimens at Customs

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare physicians payments; Medicare hospital payments; Medicare clinical lab payments; Quality Issues; Telemedicine; Drug Pricing

LobbyistCovered position, as disclosed
JENNIFER MALLARD Director, Federal Government Relations

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Pharmacy PHA

Drug Shortage, Drug Pricing, Opioid Epidemic, 340B Program

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Science/Technology SCI

Telemedicine technology; New Diagnostic Tests; Precision Medicine, biobank, NextGen Sequencing

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.